Trials / Completed
CompletedNCT00725413
A Study to Investigate the Contraceptive Efficacy and Safety of a Subdermal Etonogestrel Implant (Implanon®)(P06473)(COMPLETED)
A Study to Investigate the Contraceptive Efficacy and Safety of a Subdermal Etonogestrel Implant (Implanon®)
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 210 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- Female
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
The primary purpose of this study is to investigate the contraceptive efficacy, safety and acceptability of Organon's subdermal etonogestrel implant in healthy female volunteers in various countries in order to obtain country-specific data.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | etonogestrel implant (Implanon) | subdermal etonogestrel implant |
Timeline
- Start date
- 2001-11-01
- Primary completion
- 2005-11-01
- Completion
- 2005-11-01
- First posted
- 2008-07-30
- Last updated
- 2022-02-04
Source: ClinicalTrials.gov record NCT00725413. Inclusion in this directory is not an endorsement.